Visalytics
Visalytics
approved EB-2 (NIW)

Postdoc Research Fellow

Biochemistry · China · 2025-02-05

Processing Time
8 days
Decision Date
2025-02-05
Location
Pennsylvania
This case is from a publicly available case study. Case studies tend to feature successful outcomes and may not reflect the full range of petition results.

Proposed Endeavor

The petitioner proposes to engineer immune cells and design tumor-targeting therapies using novel immunotherapy approaches, such as lentiviral systems. The work focuses on developing conditionally dependent peptides that target tumors with high precision to enhance treatment effectiveness. The goal is to create next-generation treatment strategies that reduce cancer relapse and minimize side effects for patients.

Framework Evaluation

3 of 3 criteria met
1 Substantial Merit and National Importance Met

The endeavor addresses critical public health concerns by developing next-generation cancer treatments to reduce relapse.

2 Well-positioned to Advance the Endeavor Met

The petitioner's background and scientific output, including 411 citations, demonstrated a strong capacity to contribute to the biomedical landscape.

3 Waiver of Job Offer and Labor Certification Met

On balance, it was found beneficial to the U.S. to waive the requirements to allow the petitioner to continue life-saving research.

Why This Petition Was Approved

The petition was approved based on the petitioner's record of 9 peer-reviewed journal articles and 5 conference abstracts, which accumulated 411 citations. The evidence demonstrated that the researcher's work addresses critical therapeutic gaps in cancer treatment. All three Dhanasar prongs were satisfied, highlighting the national importance and the petitioner's strong positioning in the biomedical field.

Evidence

Evidence Types
Peer Reviewed Publications
Citations
Conference Presentations
Original Contributions
Government Alignment

Similar Cases

Others

Biotechnology · Iran

WeGreened EB-2 (NIW) approved
New Jersey 180 days 2025-09-03
The petitioner proposes to combine molecular biology methods with innovative drug delivery systems to enhance immune recognition of cancer cells. Her work focuses on developing next-generation immunotherapies that provide highly effective and less toxic treatment options for patients.
View Case

Research Scientist

Biotechnology · China

WeGreened EB-2 (NIW) approved
Florida 19 days 2025-03-26
The petitioner proposes to develop next-generation immunotherapies to treat solid tumors that are resistant to existing therapies. His work focuses on advancing biotechnologies, genome engineering, and viral delivery systems to improve patient outcomes in difficult-to-treat cancers.
View Case

Scientist

Biotechnology · Bangladesh

WeGreened EB-2 (NIW) approved
Alabama 180 days 2022-04-19
The petitioner proposes to continue his research on the production of novel, targeted drug delivery options for cancer immunotherapy. This work focuses on developing targeting peptides as low-cost, effective antitumor treatments to improve patient outcomes and cancer care standards, specifically for prostate cancer.
View Case

Postdoctoral Researcher

Biotechnology · Iran

WeGreened EB-2 (NIW) approved
Pennsylvania 126 days 2025-04-19
The petitioner proposes to develop synergistic combination therapies that merge genetic engineering of viruses and immune cells to transform cancer treatment. His work focuses on enhancing therapeutic precision while reducing toxicity, treatment costs, and overall patient burden for those with solid tumors. The endeavor aims to integrate engineered immune cells with viral vectors to achieve more efficient tumor targeting.
View Case

Frequently Asked Questions

A approved EB-2 NIW (I-140) petition means USCIS determined the petitioner met the eligibility requirements. For appealed cases, "sustained" means the appeal reversed a prior denial. The petitioner can proceed to the next step in the immigration process.

Browse More Cases

More approved cases More Biotechnology cases More cases from China

Case data sourced from publicly available petition decisions and case studies. Decision date: 2025-02-05.

Browse all cases
View Original

At a Glance

Outcome approved
Processing 8 days
Criteria Met 3 / 3
Evidence Types 5

EB-2 (NIW) Case Data

Scraped Case Data

Total Cases 3,813
Success Rate 53.7%
Sustained 2,046
Dismissed 1,671

Related Pages

EB-2 (NIW) Overview EB-2 (NIW) in China All EB-2 (NIW) Cases EB-2 (NIW) Dashboard Endeavor Search

Get Case Insights

Compare your profile against thousands of real petition outcomes. Join the waitlist for personalized analysis.

Join Waitlist